Related Experiment Videos

CD30-positive cutaneous T-cell lymphoma and response to Brentuximab Vedotin: 2 illustrative cases

Kabir Mody1, Jill S Wallace, Diane M Stearns

  • 1Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA. frederick.lansigan@hitchcock.org

Clinical Lymphoma, Myeloma & Leukemia
|January 15, 2013
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.